Prm61 - Limitations and Expected Challenges of Car-T Economic Evaluation

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2183
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Primary Bone Tumors: Challenges and Opportunities for CAR‐T Therapies

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Challenges of Driving CD30-directed CAR-T Cells to the Clinic

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Accelerating CAR Therapy in CLL: The Development and Challenges of CAR T Cell Therapy for Chronic Lymphocytic Leukemia

American Journal of Hematology
Hematology
2019English

Targeting T Cell Malignancies Using CAR-based Immunotherapy: Challenges and Potential Solutions

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

First Trimester Fetal Echocardiography Limitations and Its Expected Clinical Values

Egyptian Heart Journal
Cardiovascular MedicineCardiology
2020English

Neutron Crystallography: Opportunities, Challenges, and Limitations

Current Opinion in Structural Biology
Structural BiologyMolecular Biology
2008English

Comparative Liability Studies: Challenges and Limitations

Geneva Papers on Risk and Insurance: Issues and Practice
ManagementFinanceBusinessEconomicsAccountingEconometrics
1990English

A Survey of Mobile Computing: Limitations and Challenges

International Journal for Research in Applied Science and Engineering Technology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy